Home The current state and legal framework of preimplantation genetic diagnosis (PGD) in Japan
Article
Licensed
Unlicensed Requires Authentication

The current state and legal framework of preimplantation genetic diagnosis (PGD) in Japan

  • Mariko Nishizawa
Published/Copyright: July 27, 2005
Become an author with De Gruyter Brill
Journal of international biotechnology law
From the journal Volume 1 Issue 3

Abstract

Because of the rapid advances currently taking place in reproductive technology, Japan is being pressed to adjust its conventional approach to reproductive medicine. One example of the innovations in the technology is the reproductive technique known as preimplantation genetic diagnosis, or PGD (Chakushozen shindan or Jyuseiran shindan in Japanese), which makes it possible to select ‘healthy’ embryos for pregnancy. PGD is currently permitted in Japan under a set of guidelines issued by the Japan Society of Obstetrics and Gynaecology in 1998.

PGD is seen by some as a reproductive technique that can help couples who are at high risk of passing on serious genetic disorders to their offspring. However, it is a contested technology. Concerns are increasingly being raised about the lack of sufficient public debate and policy discussion concerning the test's ethical and social implications. The need for policy discussions and a comprehensive legal system to control all areas of reproductive medicine, including PGD, should be more widely addressed.

:
Published Online: 2005-07-27
Published in Print: 2004-05-01

© Walter de Gruyter

Downloaded on 23.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jibl.2004.1.3.105/html
Scroll to top button